Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4f00d36677b609fb09f8d53cd5fc9b55 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23K20-105 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-23 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23K20-147 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-185 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-045 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-02 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-185 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-045 |
filingDate |
2016-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c9cb60df2bf9930baa728017f3364a01 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d84c0c99ad77877446cf3bc9a28f24cf |
publicationDate |
2017-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2017147958-A1 |
titleOfInvention |
Use of oxygen-containing hydrocarbon derivative as polymyxin synergist |
abstract |
Disclosed are a pharmaceutical composition comprising a polymyxin synergist and the use thereof. The oxygen-containing hydrocarbon derivative containing 4 to 18 carbon atoms includes a fatty alcohol, a fatty acid and a fatty acid glyceride and serves as a polymyxin synergist, in particular as a synergist for a strain sensitive to the polymyxin inhibiting effect and as a drug-resistance reversal agent for polymyxin. Also disclosed is a pharmaceutical composition of the polymyxin synergist. The pharmaceutical composition is further used for preparing a drug and an animal feed additive for the treatment of a disease caused by polymyxin-sensitive bacterial infection or drug-resistant bacterial infection, and provides a more effective application space for the use of polymyxin, and is of great importance in application in the fields of pharmaceutics and animal breeding. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112755174-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112755174-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019036770-A1 |
priorityDate |
2016-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |